What caused the intraday move in IGPH.SW stock today?

The intraday drop to **CHF0.0015** and 25.00% fall coincided with high volume of **2,033,000** shares. The move appears driven by heavy selling and thin liquidity rather than a formal company announcement.

What is Meyka AI's grade for IGPH.SW stock and what does it mean?

Meyka AI rates IGPH.SW with a score out of 100: **62.62 | Grade: B | Suggestion: HOLD**. The grade combines benchmark, sector, financial growth, metrics, forecasts, and consensus. It is informational, not a recommendation.

What are the key support and resistance levels for IGPH.SW stock?

Short term support sits at the intraday low **CHF0.0015** and the year low **CHF0.0005**. Near-term resistance is the 50-day average **CHF0.00214** and recovery resistance around **CHF0.0025–CHF0.0050**.

What forecast does Meyka AI give for IGPH.SW stock?

Meyka AI's forecast model projects **CHF0.00** versus the current price **CHF0.0015**, a model-based projection implying **-100.00%**. Forecasts are model-based projections and not guarantees.

CH Stocks

Price down 25% to CHF0.0015 for IGEA Pharma (IGPH.SW) on SIX 10 Feb 2026: heavy volume may attract traders

ByHuzaifa Zahoor February 10, 2026

IGEA Pharma N.V. (IGPH.SW) fell sharply in intraday trading on SIX, sliding 25.00% to CHF0.0015 on 10 Feb 2026 as volume surged to 2,033,000 shares. The drop follows a gap lower from the previous close of CHF0.0020 and puts the share price near its intraday low of CHF0.0015. IGPH.SW stock shows elevated relative volume at 10.48x the average, signalling unusually active trading. We examine financial metrics, sector context, and short-term scenarios for traders watching this most active ticker.